Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

A new monoclonal rat anti-human lymphocyte antibody (CAMPATH-1) which lyses cells with autologous human complement was used for depletion of T lymphocytes from human bone-marrow allografts in vitro before transplantation in 11 high-risk patients. HLA-matched siblings were used as marrow donors. T-ce...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Waldmann, H, Polliak, A, Hale, G, Or, R, Cividalli, G, Weiss, L, Weshler, Z, Samuel, S, Manor, D, Brautbar, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	1984

Documenti analoghi

Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1.
di: Slavin, S, et al.
Pubblicazione: (1985)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
di: Naparstek, E, et al.
Pubblicazione: (1993)

Allogeneic bone marrow transplantation without graft-v-host disease: true tolerance of graft against the host through depletion of donor T lymphocytes pregrafting in malignant and nonmalignant disorders.
di: Slavin, S, et al.
Pubblicazione: (1987)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
di: Newman, D, et al.
Pubblicazione: (1995)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
di: Naparstek, E, et al.
Pubblicazione: (1999)

Specificity of monoclonal antibody Campath-1.
di: Hale, G, et al.
Pubblicazione: (1988)

T-CELL DEPLETION BY EXPOSURE TO CAMPATH-1G IN-VITRO PREVENTS GRAFT-VERSUS-HOST DISEASE
di: Jacobs, P, et al.
Pubblicazione: (1994)

T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
di: Jacobs, P, et al.
Pubblicazione: (1994)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
di: Hale, G, et al.
Pubblicazione: (1994)

Monoclonal antibodies for the depletion of specific subpopulations of lymphocytes.
di: Waldmann, H, et al.
Pubblicazione: (1987)

PREVENTION OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA BY T-CELL DEPLETION INVITRO PRIOR TO TRANSPLANTATION
di: Slavin, S, et al.
Pubblicazione: (1985)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
di: Hale, G, et al.
Pubblicazione: (1988)

Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
di: Hale, G, et al.
Pubblicazione: (1994)

Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: graft-versus-host disease and graft-versus-leukemia effect.
di: Novitzky, N, et al.
Pubblicazione: (1999)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
di: Williams, R, et al.
Pubblicazione: (2000)

T-cell depletion of bone marrow grafts with Campath 1 ex vivo prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation
di: Novitzky, N, et al.
Pubblicazione: (1997)

Ex vivo T-cell depletion of bone marrow grafts with campath 1 prevents graft-versus-host disease without abrogating the antileukaemic effect of transplantation.
di: Novitzky, N, et al.
Pubblicazione: (1997)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
di: Heit, W, et al.
Pubblicazione: (1986)

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
di: Waldmann, H, et al.
Pubblicazione: (1985)

Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection.
di: Hale, G, et al.
Pubblicazione: (1996)

CAMPATH-1 FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AND GRAFT-REJECTION - SUMMARY OF RESULTS FROM A MULTI-CENTRE STUDY
di: Hale, G, et al.
Pubblicazione: (1988)

T-cell-depleted allogeneic bone marrow transplantation for acute leukaemia using Campath-1 antibodies and post-transplant administration of donor's peripheral blood lymphocytes for prevention of relapse.
di: Naparstek, E, et al.
Pubblicazione: (1995)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
di: Dyer, M, et al.
Pubblicazione: (1988)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
di: Lim, S, et al.
Pubblicazione: (1993)

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.
di: Cox, A, et al.
Pubblicazione: (2005)

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES
di: Waldmann, H, et al.
Pubblicazione: (1985)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
di: Isaacs, J, et al.
Pubblicazione: (1996)

T-cell depletion of stem cell grafts with campath-1H "in the bag" followed by cyclosporin immunosuppression remains a cost effective strategy in transplantation
di: Novitzky, N, et al.
Pubblicazione: (2004)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
di: Dyer, M, et al.
Pubblicazione: (1990)

CAMPATH: from concept to clinic.
di: Waldmann, H, et al.
Pubblicazione: (2005)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
di: Hale, G, et al.
Pubblicazione: (1998)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
di: Friend, P, et al.
Pubblicazione: (1991)

Direct antibody rosette-forming reactions using monoclonal markers of lymphocyte subpopulations. Methodology and applications illustrated by investigations with rat pan-T antibodies of the CAMPATH series.
di: Wilson, AB, et al.
Pubblicazione: (1986)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
di: Isaacs, J, et al.
Pubblicazione: (1995)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
di: Rebello, P, et al.
Pubblicazione: (1999)

The repopulation capacity of bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in rhesus monkeys.
di: Gerritsen, W, et al.
Pubblicazione: (1988)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
di: Hale, G, et al.
Pubblicazione: (1986)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
di: Apperley, J, et al.
Pubblicazione: (1985)

Availability of Campath-1 antibodies for bone marrow transplantation.
di: Hale, G, et al.
Pubblicazione: (1995)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
di: Hale, G, et al.
Pubblicazione: (1988)